Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nose

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Molecular and Cellular Biochemistry|December 7, 2000
Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-beta gene expression via transcriptional and post-transcriptional mechanismsH Matsubara, Y Moriguchi, Y Mori, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 21, 2001
Safety and availability of doxazosin in treating hypertensive patients with chronic renal failureY Mori, H Matsubara, A Nose, et al.
Biochemical and Biophysical Research Communications|April 17, 2001
Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptorH Matsubara, Y Shibasaki, M Okigaki, et al.
Circulation Research|January 5, 2001
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivationS Fujiyama, H Matsubara, Y Nozawa, et al.
Hypertension (Dallas, Tex. : 1979)|September 22, 2001
Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphataseY Shibasaki, H Matsubara, Y Nozawa, et al.
Kidney International|December 12, 2001
Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cellsY Uchiyama-Tanaka, H Matsubara, Y Nozawa, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Molecular and Cellular Biochemistry|December 7, 2000
Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-beta gene expression via transcriptional and post-transcriptional mechanismsH Matsubara, Y Moriguchi, Y Mori, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|August 21, 2001
Safety and availability of doxazosin in treating hypertensive patients with chronic renal failureY Mori, H Matsubara, A Nose, et al.
Biochemical and Biophysical Research Communications|April 17, 2001
Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptorH Matsubara, Y Shibasaki, M Okigaki, et al.
Circulation Research|January 5, 2001
Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivationS Fujiyama, H Matsubara, Y Nozawa, et al.
Hypertension (Dallas, Tex. : 1979)|September 22, 2001
Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphataseY Shibasaki, H Matsubara, Y Nozawa, et al.
Kidney International|December 12, 2001
Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cellsY Uchiyama-Tanaka, H Matsubara, Y Nozawa, et al.
Pageof 6